Search clinical trials for: Suboptimal Ovarian Response

Total 18591 results

Embryolab Fertility Clinic
ART Fertility Clinics LLC

Recruiting

The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger

Ovarian Stimulation | Oocyte Donors | Human Chorionic Gonadotropin

Greece
Reproductive & Genetic Hospital of CITIC-Xiangya

Recruiting

Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response

Infertility,Female

China
Royan Institute

Completed

The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response

Reproductive Techniques, Assisted | Ovarian Stimulation

Iran, Islamic Republic of
Instituto Bernabeu

Completed

Follicular Phase Stimulation vs. Luteal Phase Stimulation in Patients Diagnosed With Suboptimal Response (SUBLUTEAL)

Improving Ovarian Stimulation; Suboptimal Responders

Spain
D.O. Ott Research Institute of Obstetrics, Gynecology...

Completed

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders (TEMPER)

Infertility, Female

Russian Federation
Nova Clinic, Russia

Unknown

Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response

Infertility, Female | Ovarian Stimulation | In Vitro Fertilisation

Russian Federation
Sisli Hamidiye Etfal Training and Research Hospital
Selcuk University

Completed

The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI (LH)

Infertility
Celgene
Bristol-Myers Squibb

Recruiting

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)

Multiple Myeloma

Austria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
Assiut University

Not yet recruiting

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

Ovarian Cancer
Insemine Humen Reproduction Centre

Not yet recruiting

Inhibin B/AFC Ratio for Ovarian Response

Infertility, Female | IVF | Ovulation Disorder
Ferring Pharmaceuticals

Recruiting

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (COCO)

Infertility, Female

China
Shi Yun
Capital Medical University

Not yet recruiting

The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)

Poor Ovarian Response

China
Exscientia GmbH
AGO Research GmbH

Recruiting

Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer (EXCYTE-1)

Epithelial Ovarian Cancer

Austria, Germany
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction (TOSCA)

Ovarian Cancer

Italy
Celgene
Bristol-Myers Squibb

Recruiting

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)

Multiple Myeloma

Austria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
AbbVie

Recruiting

Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

Diabetic Macular Edema

Greece, Portugal, Belgium, United Kingdom, Italy, Israel, China, Germany
Beni-Suef University

Not yet recruiting

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist in With Expected High Ovarian Response Undergoing in Vitro Fertilization

IVF | PCO

Egypt
Cognitive IVF a.s.
University of Pecs; Brno University Hospital; Hospital General Universitario... and other collaborators

Recruiting

A Prospective Observational Study of Biomarkers for a Personalised IVF Treatment (NAITIVE)

Poor Response to Ovulation Induction

Czechia
Bangabandhu Sheikh Mujib Medical University, Dhaka...
Department of Genetic Engineering and Biotechnology, Dhaka University

Recruiting

Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

Polycystic Ovary Syndrome | Metformin

Bangladesh
Yonsei University

Recruiting

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

Ovarian Cancer

Korea, Republic of
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

Ovarian PRP Injection in Women With POR

Poor Ovarian Response

China
Yongpeng Wang

Recruiting

A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Ovarian Cancer

China
Travera Inc
xCures

Recruiting

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (TraveraRTGx)

Melanoma | Carcinoma, Renal Cell | Carcinoma | Carcinoma, Non-Small-Cell Lung | Carcinoma, Hepatocellular | Carcinoma, Pancreatic | Pancreatic Cancer | Mesothelioma | Cholangiocarcinoma | Carcinoma, Neuroendocrine | Carcinoma, Small Cell | Pleural Effusion, Malignant | Carcinoma, Pancreatic Ductal | Carcinoma of the... and other conditions

United States
Fudan University
BGI Tianjin

Recruiting

Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer (EOC)

Ovarian Cancer

China
Instituto Bernabeu

Recruiting

Comparison of Triggers in Double Ovarian Stimulation (DuoStim). (COTRID)

IVF | LOW OVARIAN RESPONSE

Spain
Telios Pharma, Inc.

Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

Primary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET Myelofibrosis

Spain, United States, France, Poland, Italy, Germany
University of Luebeck

Recruiting

Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation (OPIF)

Infertility, Female | Sterility, Female | PRP | Premature Ovarian Insufficiency

Germany
Genesis Athens Clinic
National and Kapodistrian University of Athens

Recruiting

Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders (PRPPOR)

Infertility, Female | Ovarian Failure | Ovarian Insufficiency | Poor Response to Ovulation Induction | Reproductive Sterility | Ovary; Anomaly

Greece
Nanjing University

Recruiting

Autologous Platelet-rich Plasma to Improve Responsiveness and Embryo Quality in Patients With Poor Ovarian Response

Infertility

China
Travera Inc
John B. Amos Cancer Center

Not yet recruiting

Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs

Carcinoma, Renal Cell | Carcinoma | Carcinoma, Non-Small-Cell Lung | Carcinoma, Hepatocellular | Carcinoma, Pancreatic | Mesothelioma | AML | Cholangiocarcinoma | Stage IV Lung Cancer | Carcinoma, Neuroendocrine | Stage IV Breast Cancer | Carcinoma, Ductal | Malignant Ascites | Carcinoma Prostate | Stage III Breast Cancer and other conditions

United States
National Cancer Institute (NCI)

Recruiting

Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

Ovarian Cancer | Gastrointestinal Cancer | Peritoneal Carcinomatosis | Peritoneal Mesothelioma | Appendiceal Cancer

United States
Nanjing University

Recruiting

A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

Poor Ovarian Response

China
The First Affiliated Hospital with Nanjing Medical...

Not yet recruiting

Transplantation of hAMSCs for Woman With DOR

Diminished Ovarian Response

China
Wuhan Union Hospital, China

Recruiting

Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib

CML-CP; Mutation;Suboptimal Response or Failure in TKI

China
Shandong University

Recruiting

Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Objective Response Rate

China
University of Manchester
Cancer Research UK; Centre for Trials Research, Cardiff University

Recruiting

Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1 (VALTIVE1)

Ovary Cancer

United Kingdom
Kartos Therapeutics, Inc.

Recruiting

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib

Myelofibrosis

United States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
Azienda Ospedaliero-Universitaria di Modena

Recruiting

The Relationship Between Serum AMH Dynamics and Early or Normal Ovarian Response to Corifollitropin Alfa (ACO)

Infertility, Female

Italy
University of Utah
Novartis; Acrotech Biopharma

Recruiting

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics (CHARGE)

Metastatic Breast Cancer | Recurrent Ovarian Carcinoma

United States
American University of Beirut Medical Center

Recruiting

Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial

Poor Ovarian Response

Lebanon
New Discovery LLC
Beijing Ditan Hospital

Recruiting

Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides

Hepatitis B, Chronic

China
Carilion Clinic
Provepharm Life Solutions

Recruiting

Methylene Blue as a Third-line Vasopressor in Septic Shock

Septic Shock

United States
Taproot Health

Recruiting

The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)

Melanoma | Sarcoma | Kidney Cancer | Adenocarcinoma | Renal Cell Carcinoma | Cervical Cancer | Acute Myeloid Leukemia | Stomach Cancer | Breast Cancer | Head and Neck Neoplasms | Nasopharyngeal Carcinoma | Glioblastoma | Astrocytoma | Multiple Myeloma | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer and other conditions

United States
Barzilai Medical Center

Recruiting

Improving in Vitro Fertilization in Women With Poor Ovarian Response

Poor Ovarian Response | Ovarian Insufficiency

Israel
Centre Francois Baclesse

Recruiting

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response (OVAREX)

Ovarian Cancer

France
Instituto Valenciano de Infertilidad, IVI Alicante
Fundación IVI; Syntax for Science, S.L; Merck, S.L., Spain

Recruiting

Recombinant LH Prior to Ovarian Stimulation in Poor Ovarian Responders (PRE-LH) (PRE-LH)

Infertility, Female

Spain
University Hospital, Angers

Recruiting

Conversion of in Vitro Fertilization Cycles to Intrauterine Inseminations in Patients With a Poor Ovarian Response to Stimulation (ConFIRM)

Infertility

France, Guadeloupe
National Institute of Diabetes and Digestive and...

Recruiting

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

Polycystic Ovary Syndrome

United States
Institut Curie

Recruiting

Prospective Biobanking Study in Ovarian, Breast, Head and Neck and Cervical Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) (SCANDARE)

Cervical Cancer | Head and Neck Cancer | Ovarian Cancer | Triple-Negative Breast Cancer

France
University Health Network, Toronto

Recruiting

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host (REFLECT)

Breast Cancer | Breast Neoplasms | Colorectal Neoplasms | Colorectal Cancer | Ovarian Cancer | Ovarian Neoplasm

Canada

Search clinical trials for: Suboptimal Ovarian Response

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations